Sadera, Conchita A.
HRN: 12-86-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2026
CEFTRIAXONE 1G (VIAL)
08/03/2026
08/10/2026
IV
2G
Q24
CAP MR
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: